Elkeles Tamar reported grant involving 49,923 shares of PETMED EXPRESS INC at $0.00 for $0 on Sep 17, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Sep 21, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
49,923Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
49,923Direct
Trade date
Sep 17, 2026Grant
Filed
Sep 21, 2026, 8:58 AM ET4-day reporting delay
Accession
0001040130-26-000051Code A · Transaction 226439
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

PETS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PETS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +13%1w ago +10%1d ago +10%
Returns since7d −13%30d −25%90d180d1y

Footnotes in full

F1: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan which will vest in its entirety on September 17, 2027, subject to continued service on the Board of Directors.